167 related articles for article (PubMed ID: 2925240)
1. Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates.
Verheul AF; Versteeg AA; De Reuver MJ; Jansze M; Snippe H
Infect Immun; 1989 Apr; 57(4):1078-83. PubMed ID: 2925240
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.
van de Wijgert JH; Verheul AF; Snippe H; Check IJ; Hunter RL
Infect Immun; 1991 Aug; 59(8):2750-7. PubMed ID: 1855991
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.
DeVelasco EA; Dekker HA; Antal P; Jalink KP; van Strijp JA; Verheul AF; Verhoef J; Snippe H
Vaccine; 1994 Nov; 12(15):1419-22. PubMed ID: 7887020
[TBL] [Abstract][Full Text] [Related]
4. Measurement of the humoral immune response against Streptococcus pneumoniae type 14-derived antigens by an ELISA and ELISPOT assay based on biotin-avidin technology.
Verheul AF; Versteeg AA; Westerdaal NA; Van Dam GJ; Jansze M; Snippe H
J Immunol Methods; 1990 Jan; 126(1):79-87. PubMed ID: 2303727
[TBL] [Abstract][Full Text] [Related]
5. Nonionic block polymer surfactants modulate the humoral immune response against Streptococcus pneumoniae-derived hexasaccharide-protein conjugates.
Zigterman GJ; Schotanus K; Ernste EB; Van Dam GJ; Jansze M; Snippe H; Willers JM
Infect Immun; 1989 Sep; 57(9):2712-8. PubMed ID: 2759707
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.
Zigterman JW; van Dam JE; Snippe H; Rotteveel FT; Jansze M; Willers JM; Kamerling JP; Vliegenthart JF
Infect Immun; 1985 Feb; 47(2):421-8. PubMed ID: 3881349
[TBL] [Abstract][Full Text] [Related]
7. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
[TBL] [Abstract][Full Text] [Related]
8. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
Chu C; Schneerson R; Robbins JB; Rastogi SC
Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
[TBL] [Abstract][Full Text] [Related]
9. Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.
Benaissa-Trouw B; Lefeber DJ; Kamerling JP; Vliegenthart JF; Kraaijeveld K; Snippe H
Infect Immun; 2001 Jul; 69(7):4698-701. PubMed ID: 11402020
[TBL] [Abstract][Full Text] [Related]
10. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
Mawas F; Feavers IM; Corbel MJ
Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.
Khan AQ; Lees A; Snapper CM
J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364
[TBL] [Abstract][Full Text] [Related]
12. Higher Cytokine and Opsonizing Antibody Production Induced by Bovine Serum Albumin (BSA)-Conjugated Tetrasaccharide Related to
Kurbatova EA; Akhmatova NK; Zaytsev AE; Akhmatova EA; Egorova NB; Yastrebova NE; Sukhova EV; Yashunsky DV; Tsvetkov YE; Nifantiev NE
Front Immunol; 2020; 11():578019. PubMed ID: 33343566
[TBL] [Abstract][Full Text] [Related]
13. Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.
Peeters C; Tenbergen-Meekes AM; Poolmann J; Zegers B; Rijkers G
Med Microbiol Immunol; 1992; 181(1):35-42. PubMed ID: 1579084
[TBL] [Abstract][Full Text] [Related]
14. Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies.
Pawlowski A; Källenius G; Svenson SB
Vaccine; 2000 Mar; 18(18):1873-85. PubMed ID: 10699336
[TBL] [Abstract][Full Text] [Related]
15. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
[TBL] [Abstract][Full Text] [Related]
16. Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.
Lefeber DJ; Benaissa-Trouw B; Vliegenthart JF; Kamerling JP; Jansen WT; Kraaijeveld K; Snippe H
Infect Immun; 2003 Dec; 71(12):6915-20. PubMed ID: 14638780
[TBL] [Abstract][Full Text] [Related]
17. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
[TBL] [Abstract][Full Text] [Related]
18. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
Safari D; Dekker HA; Rijkers G; Snippe H
Vaccine; 2011 Jan; 29(4):849-54. PubMed ID: 21111776
[TBL] [Abstract][Full Text] [Related]
19. Revised interpretation of the immunological results obtained with pneumococcal polysaccharide 17F derived synthetic di-, tri- and tetrasaccharide conjugates in mice and rabbits.
Jansen WT; Verheul AF; Veeneman GH; van Boom JH; Snippe H
Vaccine; 2001 Oct; 20(1-2):19-21. PubMed ID: 11567741
[TBL] [Abstract][Full Text] [Related]
20. B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.
McCool TL; Harding CV; Greenspan NS; Schreiber JR
Infect Immun; 1999 Sep; 67(9):4862-9. PubMed ID: 10456942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
